世界の静脈血栓塞栓症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Venous Thromboembolism Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5896 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、静脈血栓塞栓症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Xa因子阻害剤、直接トロンビン阻害剤、ヘパリン、ビタミンK拮抗薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・静脈血栓塞栓症治療薬の市場動向 ・企業の競争状況、市場シェア ・静脈血栓塞栓症治療薬の種類別市場規模（Xa因子阻害剤、直接トロンビン阻害剤、ヘパリン、ビタミンK拮抗薬、その他） ・静脈血栓塞栓症治療薬の用途別市場規模（病院薬局、小売薬局、その他） ・静脈血栓塞栓症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・静脈血栓塞栓症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・静脈血栓塞栓症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・静脈血栓塞栓症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・静脈血栓塞栓症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Sanofi、Boehringer Ingelheim、Daiichi Sankyo、Bristol-Myers Squibb (BMS)、Bayer HealthCare、Pfizer、Leo Pharma、Portola Pharmaceuticals、ThromboGenics、Ionis Pharmaceuticals、GlycoMimetics、BioInvent International） ・結論

Market Analysis and Insights: Global Venous Thromboembolism Therapeutics Market
The global Venous Thromboembolism Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Venous Thromboembolism Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Venous Thromboembolism Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Venous Thromboembolism Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Venous Thromboembolism Therapeutics market.

Global Venous Thromboembolism Therapeutics Scope and Market Size
Venous Thromboembolism Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Factor Xa Inhibitors
Direct Thrombin Inhibitors
Heparin
Vitamin K Antagonists
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
Daiichi Sankyo
Bristol-Myers Squibb (BMS)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Factor Xa Inhibitors
1.2.3 Direct Thrombin Inhibitors
1.2.4 Heparin
1.2.5 Vitamin K Antagonists
1.2.6 Other
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Venous Thromboembolism Therapeutics Market Perspective (2016-2027)
2.2 Venous Thromboembolism Therapeutics Growth Trends by Regions
2.2.1 Venous Thromboembolism Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Venous Thromboembolism Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Venous Thromboembolism Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Venous Thromboembolism Therapeutics Industry Dynamic
2.3.1 Venous Thromboembolism Therapeutics Market Trends
2.3.2 Venous Thromboembolism Therapeutics Market Drivers
2.3.3 Venous Thromboembolism Therapeutics Market Challenges
2.3.4 Venous Thromboembolism Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue
3.1.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Venous Thromboembolism Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Venous Thromboembolism Therapeutics Revenue
3.4 Global Venous Thromboembolism Therapeutics Market Concentration Ratio
3.4.1 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Revenue in 2020
3.5 Venous Thromboembolism Therapeutics Key Players Head office and Area Served
3.6 Key Players Venous Thromboembolism Therapeutics Product Solution and Service
3.7 Date of Enter into Venous Thromboembolism Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Venous Thromboembolism Therapeutics Breakdown Data by Type
4.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2022-2027)

5 Venous Thromboembolism Therapeutics Breakdown Data by Application
5.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Venous Thromboembolism Therapeutics Market Size (2016-2027)
6.2 North America Venous Thromboembolism Therapeutics Market Size by Type
6.2.1 North America Venous Thromboembolism Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Venous Thromboembolism Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Venous Thromboembolism Therapeutics Market Size by Type (2016-2027)
6.3 North America Venous Thromboembolism Therapeutics Market Size by Application
6.3.1 North America Venous Thromboembolism Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Venous Thromboembolism Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Venous Thromboembolism Therapeutics Market Size by Application (2016-2027)
6.4 North America Venous Thromboembolism Therapeutics Market Size by Country
6.4.1 North America Venous Thromboembolism Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Venous Thromboembolism Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Venous Thromboembolism Therapeutics Market Size (2016-2027)
7.2 Europe Venous Thromboembolism Therapeutics Market Size by Type
7.2.1 Europe Venous Thromboembolism Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Venous Thromboembolism Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Venous Thromboembolism Therapeutics Market Size by Type (2016-2027)
7.3 Europe Venous Thromboembolism Therapeutics Market Size by Application
7.3.1 Europe Venous Thromboembolism Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Venous Thromboembolism Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Venous Thromboembolism Therapeutics Market Size by Application (2016-2027)
7.4 Europe Venous Thromboembolism Therapeutics Market Size by Country
7.4.1 Europe Venous Thromboembolism Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Venous Thromboembolism Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type
8.2.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application
8.3.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region
8.4.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Venous Thromboembolism Therapeutics Market Size (2016-2027)
9.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type
9.2.1 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Venous Thromboembolism Therapeutics Market Size by Application
9.3.1 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Venous Thromboembolism Therapeutics Market Size by Country
9.4.1 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type
10.2.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application
10.3.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country
10.4.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Venous Thromboembolism Therapeutics Introduction
11.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Introduction
11.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.4.5 Daiichi Sankyo Recent Development
11.5 Bristol-Myers Squibb (BMS)
11.5.1 Bristol-Myers Squibb (BMS) Company Details
11.5.2 Bristol-Myers Squibb (BMS) Business Overview
11.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Introduction
11.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb (BMS) Recent Development
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.6.5 Bayer HealthCare Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Venous Thromboembolism Therapeutics Introduction
11.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Leo Pharma
11.8.1 Leo Pharma Company Details
11.8.2 Leo Pharma Business Overview
11.8.3 Leo Pharma Venous Thromboembolism Therapeutics Introduction
11.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.8.5 Leo Pharma Recent Development
11.9 Portola Pharmaceuticals
11.9.1 Portola Pharmaceuticals Company Details
11.9.2 Portola Pharmaceuticals Business Overview
11.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.9.5 Portola Pharmaceuticals Recent Development
11.10 ThromboGenics
11.10.1 ThromboGenics Company Details
11.10.2 ThromboGenics Business Overview
11.10.3 ThromboGenics Venous Thromboembolism Therapeutics Introduction
11.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.10.5 ThromboGenics Recent Development
11.11 Ionis Pharmaceuticals
11.11.1 Ionis Pharmaceuticals Company Details
11.11.2 Ionis Pharmaceuticals Business Overview
11.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.11.4 Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.11.5 Ionis Pharmaceuticals Recent Development
11.12 GlycoMimetics
11.12.1 GlycoMimetics Company Details
11.12.2 GlycoMimetics Business Overview
11.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Introduction
11.12.4 GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.12.5 GlycoMimetics Recent Development
11.13 BioInvent International
11.13.1 BioInvent International Company Details
11.13.2 BioInvent International Business Overview
11.13.3 BioInvent International Venous Thromboembolism Therapeutics Introduction
11.13.4 BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2016-2021)
11.13.5 BioInvent International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Factor Xa Inhibitors
Table 3. Key Players of Direct Thrombin Inhibitors
Table 4. Key Players of Heparin
Table 5. Key Players of Vitamin K Antagonists
Table 6. Key Players of Other
Table 7. Global Venous Thromboembolism Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Venous Thromboembolism Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Venous Thromboembolism Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Venous Thromboembolism Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Venous Thromboembolism Therapeutics Market Share by Regions (2022-2027)
Table 13. Venous Thromboembolism Therapeutics Market Trends
Table 14. Venous Thromboembolism Therapeutics Market Drivers
Table 15. Venous Thromboembolism Therapeutics Market Challenges
Table 16. Venous Thromboembolism Therapeutics Market Restraints
Table 17. Global Venous Thromboembolism Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Venous Thromboembolism Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Thromboembolism Therapeutics as of 2020)
Table 20. Ranking of Global Top Venous Thromboembolism Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Venous Thromboembolism Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Venous Thromboembolism Therapeutics Product Solution and Service
Table 24. Date of Enter into Venous Thromboembolism Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Venous Thromboembolism Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Venous Thromboembolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Venous Thromboembolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Venous Thromboembolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Venous Thromboembolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Venous Thromboembolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Venous Thromboembolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Venous Thromboembolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Venous Thromboembolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Venous Thromboembolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Venous Thromboembolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Venous Thromboembolism Therapeutics Product
Table 67. Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Venous Thromboembolism Therapeutics Product
Table 72. Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product
Table 77. Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. Daiichi Sankyo Company Details
Table 80. Daiichi Sankyo Business Overview
Table 81. Daiichi Sankyo Venous Thromboembolism Therapeutics Product
Table 82. Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Daiichi Sankyo Recent Development
Table 84. Bristol-Myers Squibb (BMS) Company Details
Table 85. Bristol-Myers Squibb (BMS) Business Overview
Table 86. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product
Table 87. Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb (BMS) Recent Development
Table 89. Bayer HealthCare Company Details
Table 90. Bayer HealthCare Business Overview
Table 91. Bayer HealthCare Venous Thromboembolism Therapeutics Product
Table 92. Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Bayer HealthCare Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Venous Thromboembolism Therapeutics Product
Table 97. Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Leo Pharma Company Details
Table 100. Leo Pharma Business Overview
Table 101. Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Leo Pharma Recent Development
Table 103. Portola Pharmaceuticals Company Details
Table 104. Portola Pharmaceuticals Business Overview
Table 105. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 106. Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Portola Pharmaceuticals Recent Development
Table 108. ThromboGenics Company Details
Table 109. ThromboGenics Business Overview
Table 110. ThromboGenics Venous Thromboembolism Therapeutics Product
Table 111. ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 112. ThromboGenics Recent Development
Table 113. Ionis Pharmaceuticals Company Details
Table 114. Ionis Pharmaceuticals Business Overview
Table 115. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 116. Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Ionis Pharmaceuticals Recent Development
Table 118. GlycoMimetics Company Details
Table 119. GlycoMimetics Business Overview
Table 120. GlycoMimetics Venous Thromboembolism Therapeutics Product
Table 121. GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 122. GlycoMimetics Recent Development
Table 123. BioInvent International Company Details
Table 124. BioInvent International Business Overview
Table 125. BioInvent International Venous Thromboembolism Therapeutics Product
Table 126. BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2016-2021) & (US$ Million)
Table 127. BioInvent International Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Venous Thromboembolism Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Factor Xa Inhibitors Features
Figure 3. Direct Thrombin Inhibitors Features
Figure 4. Heparin Features
Figure 5. Vitamin K Antagonists Features
Figure 6. Other Features
Figure 7. Global Venous Thromboembolism Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Venous Thromboembolism Therapeutics Report Years Considered
Figure 12. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Venous Thromboembolism Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Venous Thromboembolism Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Venous Thromboembolism Therapeutics Market Share by Players in 2020
Figure 17. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Thromboembolism Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2020
Figure 19. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Venous Thromboembolism Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Venous Thromboembolism Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Venous Thromboembolism Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Venous Thromboembolism Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Venous Thromboembolism Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Venous Thromboembolism Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Region (2016-2027)
Figure 41. China Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Venous Thromboembolism Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Venous Thromboembolism Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Venous Thromboembolism Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Venous Thromboembolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Johnson & Johnson Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 63. Daiichi Sankyo Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 64. Bristol-Myers Squibb (BMS) Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 65. Bayer HealthCare Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 67. Leo Pharma Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 68. Portola Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 69. ThromboGenics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 70. Ionis Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 71. GlycoMimetics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 72. BioInvent International Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---